Effectiveness of Neuromuscular Electrical Stimulation Added to Oral Motor Therapy in Cerebral Palsy
Starting soon · Not applicable · Has a placebo group
Conditions studied: Cerebral Palsy (CP), Drooling
In brief
This randomized, controlled, single-blind trial aims to investigate the effectiveness of neuromuscular electrical stimulation (NMES) combined with oral motor therapy in reducing drooling severity among children with cerebral palsy. Participants will be allocated to an intervention group (oral motor therapy plus NMES), a control group (oral motor therapy alone) and a sham group (oral motor therapy with placebo NMES).
Key facts
- Study ID
- NCT07069257
- Run by
- Aslinur Keles Ercisli, MD, PhD
- People needed
- 30
- Starts
- 2026-05-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2026-04-15
Who can join
Age: 4 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of cerebral palsy (unilateral/bilateral spastic, ataxic, dyskinetic, or mixed type)
- Presence of drooling control problems
- Age between 4 and 17 years
- Gross Motor Function Classification System (GMFCS) levels 2, 3, 4, or 5
- Stable drooling severity for at least one month prior to enrollment
- Drooling Severity and Frequency Scale (DSFS) score of 3 or higher
You may not qualify if…
- Diagnosis of dysphagia
- Use of medications affecting drooling within the past 72 hours
- Upper respiratory tract infection and/or salivary gland infection during the study period
- History of botulinum toxin injection to the salivary glands
Where it is running
- Fatih Sultan Mehmet Training and Research Hospital — Ataşehir, Istanbul, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.